Pharmaceutical Excipients Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

In a world increasingly grappling with the burden of chronic diseases and lifestyle disorders, the demand for medicines has reached unprecedented levels. This surge is fueled by a combination of factors including heightened awareness towards physical well-being, rising instances of conditions like diabetes and obesity-related disorders, and an overall increase in chronic ailments. As a result, the production and demand for drugs have seen a significant uptick, consequently driving the market for pharmaceutical excipients.

Emerging Economies Propel Growth in Pharmaceutical Excipients Market

Notably, the past few years have witnessed a remarkable surge in demand for pharmaceutical excipients, particularly from emerging economies across Asia Pacific and East Africa. These regions, characterized by a burgeoning local drug manufacturing industry, have shown a preference for cheaper quality excipients. Conversely, developed economies with advanced manufacturing practices are witnessing a demand shift towards superior quality excipients, albeit at a slower rate compared to their emerging counterparts.

Government Initiatives Spur Demand in Emerging Markets

Government initiatives aimed at bolstering healthcare services and drug manufacturing in emerging economies such as India, China, Brazil, Kenya, and Nigeria have played a pivotal role in driving the demand for excipients. These initiatives have not only boosted the healthcare infrastructure but have also facilitated an environment conducive to pharmaceutical innovation and production.

Growing Preference for Oral Solid Drug Formulations

The preference for oral solid drug formulations has been on the rise owing to their ease of consumption, particularly among diverse patient classes including children. This trend has led to an increased demand for excipients, as oral dosage forms typically require a higher amount of excipients during the manufacturing process. Moreover, the advent of patient-centric approaches by drug manufacturers has spurred innovation in solid oral product forms such as orally disintegrating granules, effervescent tablets, lozenges, instant drinks, and chewable tablets, further amplifying the demand for excipients.

Regulatory Challenges and Opportunities

Despite the promising growth trajectory, the development of novel pharmaceutical excipients faces regulatory hurdles. The lack of separate guidelines for manufacturing and approval of excipients poses challenges for R&D initiatives. Additionally, the current regulatory landscape holds excipients accountable in the event of a new drug approval failure, leading to financial setbacks for both drug and excipient manufacturers. However, efforts to streamline regulatory processes and foster innovation remain underway, offering potential avenues for future growth.

Pharmaceutical Excipients Market Analysis

Analysts anticipate a significant surge in demand for plant-based pharmaceutical excipients, driven by the high incidence of chronic diseases and the increasing preference for oral formulations. Synthetic excipients currently dominate the market, with natural plant-based excipients following closely behind. Notably, synthetic excipients are perceived as more complex in nature, while plant-based excipients offer ease of manufacturing and find wide applications, particularly in taste-masking of drugs. The synthetic excipient segment is poised to witness robust growth, underscoring the dynamic landscape of the pharmaceutical excipients market.

As the pharmaceutical landscape continues to evolve, fueled by technological advancements and shifting consumer preferences, the role of excipients in drug formulation and delivery remains indispensable. With a focus on innovation, regulatory compliance, and market dynamics, stakeholders in the pharmaceutical excipients industry are poised to capitalize on emerging opportunities and drive sustainable growth in the global market.

Competitive Analysis

Key players mentioned in the global pharmaceutical excipients market research report are :

BASF SE,
Evonik Industries AG,
Innophos Holdings Inc.,
The Lubrizol Corporation,
The Dow Chemical Company,
Wacker Chemie AG and
Ashland Inc.
Other.

Market Segmentation:

By Chemistry Type
- Plant-based excipients
- Animal-based excipients
- Mineral-based excipients
- Synthetic excipients
By Application Type
- Oral Formulation
- Topical Formulation
- Parenteral Formulation
- Others
By Functionality
- Binders
- Glidents
- Diluents
- Disintegrants
- Other
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa

1. Executive Summary

1.1. Global Pharmaceutical Excipients Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Pharmaceutical Excipients Production Output, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis by Product Type, 2018 - 2023
4.2. Prominent Factor Affecting Pharmaceutical Excipients Prices
4.3. Global Average Price Analysis by Region

5. Global Pharmaceutical Excipients Market Outlook, 2018 - 2031

5.1. Global Pharmaceutical Excipients Market Outlook, by Chemistry Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Plant-based excipients
  - 5.1.1.2. Animal-based excipients
  - 5.1.1.3. Mineral-based excipients
  - 5.1.1.4. Synthetic excipients
5.2. Global Pharmaceutical Excipients Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Oral Formulation
  - 5.2.1.2. Topical Formulation
  - 5.2.1.3. Parenteral Formulation
  - 5.2.1.4. Others
5.3. Global Pharmaceutical Excipients Market Outlook, by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Binders
  - 5.3.1.2. Glidents
  - 5.3.1.3. Diluents
  - 5.3.1.4. Disintegrants
  - 5.3.1.5. Others
5.4. Global Pharmaceutical Excipients Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. North America
  - 5.4.1.2. Europe
  - 5.4.1.3. Asia Pacific
  - 5.4.1.4. Latin America
  - 5.4.1.5. Middle East & Africa

6. North America Pharmaceutical Excipients Market Outlook, 2018 - 2031

6.1. North America Pharmaceutical Excipients Market Outlook, by Chemistry Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Plant-based excipients
  - 6.1.1.2. Animal-based excipients
  - 6.1.1.3. Mineral-based excipients
  - 6.1.1.4. Synthetic excipients
6.2. North America Pharmaceutical Excipients Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Oral Formulation
  - 6.2.1.2. Topical Formulation
  - 6.2.1.3. Parenteral Formulation
  - 6.2.1.4. Others
6.3. North America Pharmaceutical Excipients Market Outlook, by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Binders
  - 6.3.1.2. Glidents
  - 6.3.1.3. Diluents
  - 6.3.1.4. Disintegrants
  - 6.3.1.5. Others
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Pharmaceutical Excipients Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. U.S. Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.2. U.S. Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.3. U.S. Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.4. Canada Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.5. Canada Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.6. Canada Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Pharmaceutical Excipients Market Outlook, 2018 - 2031

7.1. Europe Pharmaceutical Excipients Market Outlook, by Chemistry Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Plant-based excipients
  - 7.1.1.2. Animal-based excipients
  - 7.1.1.3. Mineral-based excipients
  - 7.1.1.4. Synthetic excipients
7.2. Europe Pharmaceutical Excipients Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Oral Formulation
  - 7.2.1.2. Topical Formulation
  - 7.2.1.3. Parenteral Formulation
  - 7.2.1.4. Others
7.3. Europe Pharmaceutical Excipients Market Outlook, by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Binders
  - 7.3.1.2. Glidents
  - 7.3.1.3. Diluents
  - 7.3.1.4. Disintegrants
  - 7.3.1.5. Others
- 7.3.2. Attractiveness Analysis
7.4. Europe Pharmaceutical Excipients Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Germany Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.2. Germany Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.3. Germany Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.4. U.K. Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.5. U.K. Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.6. U.K. Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.7. France Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.8. France Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.9. France Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.10. Italy Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.11. Italy Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.12. Italy Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.13. Turkey Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.14. Turkey Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.15. Turkey Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.16. Russia Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.17. Russia Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.18. Russia Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.19. Rest of Europe Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.20. Rest of Europe Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.21. Rest of Europe Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Pharmaceutical Excipients Market Outlook, 2018 - 2031

8.1. Asia Pacific Pharmaceutical Excipients Market Outlook, by Chemistry Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Plant-based excipients
  - 8.1.1.2. Animal-based excipients
  - 8.1.1.3. Mineral-based excipients
  - 8.1.1.4. Synthetic excipients
8.2. Asia Pacific Pharmaceutical Excipients Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Oral Formulation
  - 8.2.1.2. Topical Formulation
  - 8.2.1.3. Parenteral Formulation
  - 8.2.1.4. Others
8.3. Asia Pacific Pharmaceutical Excipients Market Outlook, by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Binders
  - 8.3.1.2. Glidents
  - 8.3.1.3. Diluents
  - 8.3.1.4. Disintegrants
  - 8.3.1.5. Others
8.4. Asia Pacific Pharmaceutical Excipients Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. China Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.2. China Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.3. China Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.4. Japan Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.5. Japan Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.6. Japan Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.7. South Korea Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.8. South Korea Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.9. South Korea Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.10. India Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.11. India Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.12. India Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.13. Southeast Asia Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.14. Southeast Asia Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.15. Southeast Asia Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.16. Rest of Asia Pacific Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.17. Rest of Asia Pacific Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.18. Rest of Asia Pacific Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Pharmaceutical Excipients Market Outlook, 2018 - 2031

9.1. Latin America Pharmaceutical Excipients Market Outlook, by Chemistry Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. Plant-based excipients
  - 9.1.1.2. Animal-based excipients
  - 9.1.1.3. Mineral-based excipients
  - 9.1.1.4. Synthetic excipients
9.2. Latin America Pharmaceutical Excipients Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.2.1. Key Highlights
  - 9.2.1.1. Oral Formulation
  - 9.2.1.2. Topical Formulation
  - 9.2.1.3. Parenteral Formulation
  - 9.2.1.4. Others
9.3. Latin America Pharmaceutical Excipients Market Outlook, by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Binders
  - 9.3.1.2. Glidents
  - 9.3.1.3. Diluents
  - 9.3.1.4. Disintegrants
  - 9.3.1.5. Others
- 9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Pharmaceutical Excipients Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.4.1. Key Highlights
  - 9.4.1.1. Brazil Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.2. Brazil Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.3. Brazil Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.4. Mexico Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.5. Mexico Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.6. Mexico Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.7. Argentina Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.8. Argentina Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.9. Argentina Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.10. Rest of Latin America Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.11. Rest of Latin America Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.12. Rest of Latin America Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Pharmaceutical Excipients Market Outlook, 2018 - 2031

10.1. Middle East & Africa Pharmaceutical Excipients Market Outlook, by Chemistry Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.1.1. Key Highlights
  - 10.1.1.1. Plant-based excipients
  - 10.1.1.2. Animal-based excipients
  - 10.1.1.3. Mineral-based excipients
  - 10.1.1.4. Synthetic excipients
10.2. Middle East & Africa Pharmaceutical Excipients Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.2.1. Key Highlights
  - 10.2.1.1. Oral Formulation
  - 10.2.1.2. Topical Formulation
  - 10.2.1.3. Parenteral Formulation
  - 10.2.1.4. Others
10.3. Middle East & Africa Pharmaceutical Excipients Market Outlook, by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.3.1. Key Highlights
  - 10.3.1.1. Binders
  - 10.3.1.2. Glidents
  - 10.3.1.3. Diluents
  - 10.3.1.4. Disintegrants
  - 10.3.1.5. Others
- 10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Pharmaceutical Excipients Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.4.1. Key Highlights
  - 10.4.1.1. GCC Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.2. GCC Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.3. GCC Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.4. South Africa Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.5. South Africa Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.6. South Africa Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.7. Egypt Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.8. Egypt Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.9. Egypt Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.10. Nigeria Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.11. Nigeria Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.12. Nigeria Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.13. Rest of Middle East & Africa Pharmaceutical Excipients Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.14. Rest of Middle East & Africa Pharmaceutical Excipients Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.15. Rest of Middle East & Africa Pharmaceutical Excipients Market by Functionality, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By End User vs By Application Heatmap
11.2. Company Market Share Analysis, 2022
11.3. Competitive Dashboard
11.4. Company Profiles
- 11.4.1. BASF SE
  - 11.4.1.1. Company Overview
  - 11.4.1.2. Product Portfolio
  - 11.4.1.3. Financial Overview
  - 11.4.1.4. Business Strategies and Development
- 11.4.2. Evonik Industries AG,
  - 11.4.2.1. Company Overview
  - 11.4.2.2. Product Portfolio
  - 11.4.2.3. Financial Overview
  - 11.4.2.4. Business Strategies and Development
- 11.4.3. Innophos Holdings Inc
  - 11.4.3.1. Company Overview
  - 11.4.3.2. Product Portfolio
  - 11.4.3.3. Financial Overview
  - 11.4.3.4. Business Strategies and Development
- 11.4.4. The Lubrizol Corporation
  - 11.4.4.1. Company Overview
  - 11.4.4.2. Product Portfolio
  - 11.4.4.3. Financial Overview
  - 11.4.4.4. Business Strategies and Development
- 11.4.5. The Dow Chemical Company
  - 11.4.5.1. Company Overview
  - 11.4.5.2. Product Portfolio
  - 11.4.5.3. Financial Overview
  - 11.4.5.4. Business Strategies and Development
- 11.4.6. Wacker Chemie AG and
  - 11.4.6.1. Company Overview
  - 11.4.6.2. Product Portfolio
  - 11.4.6.3. Financial Overview
  - 11.4.6.4. Business Strategies and Development
- 11.4.7. Ashland Inc.
  - 11.4.7.1. Company Overview
  - 11.4.7.2. Product Portfolio
  - 11.4.7.3. Financial Overview
  - 11.4.7.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations